Early long-term low-dosage colchicine and major adverse cardiovascular events in patients with acute myocardial infarction: a systematic review and meta-analysis

Early long-term low-dosage colchicine and major adverse cardiovascular events in patients with acute myocardial infarction: a systematic review and meta-analysis

BackgroundCurrent evidence on the efficacy and safety of colchicine after acute myocardial infarction (AMI) remains controversial. This study aims to clarify early low-dose long-term colchicine's exact efficacy and safety in AMI patients via more studies.MethodsWe searched PubMed, Web of Scienc...

Full description

Bibliographic Details
Main Authors:	Yifang Zhou, Yidan Liu, Ruixiang Zeng, Wenjie Qiu, Yunhong Zhao, Yuanshen Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	colchicine myocardial infarction major adverse cardiovascular events CRP inflammation
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1194605/full

Similar Items

Serum Vaspin as a Predictor of Adverse Cardiac Events in Acute Myocardial Infarction
by: Xiang Zhou, et al.
Published: (2019-01-01)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
by: Meifan Zheng, et al.
Published: (2020-06-01)

Colchicine to Prevent Sympathetic Denervation after an Acute Myocardial Infarction: The COLD-MI Trial Protocol
by: Fabien Huet, et al.
Published: (2021-09-01)

Prediction of major adverse cardiovascular events following acute myocardial infarction using electrocardiogram DETERMINE score
by: Zeyan Liu, et al.
Published: (2024-12-01)

Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis
by: Jason Nogic, et al.
Published: (2023-01-01)

Low-dose colchicine prevents sympathetic denervation after myocardial ischemia-reperfusion: a new potential protective mechanism
by: Fabien Huet, et al.
Published: (2021-02-01)

Colchicine as an Adjuvant Therapy for Coronary Artery Disease: A Systematic Review
by: Nobian Andre, et al.
Published: (2020-11-01)

Time to benefit of colchicine in patients with cardiovascular disease: A pooled analysis of randomized controlled trials
by: Haonan Sun, et al.
Published: (2024-05-01)

Risk of coronary artery disease in patients with gout on treatment with Colchicine: A systematic review and meta-analysis
by: Muhammad U. Siddiqui, et al.
Published: (2023-04-01)

Role of inflammation and evidence for the use of colchicine in patients with acute coronary syndrome
by: Juan Francisco Bulnes, et al.
Published: (2024-06-01)

Predictive Model for Long-term Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
by: Qin LI, Xin TAN, Wenxi JIANG, Meng YUAN, Hui NI, Yuan WANG, Jie DU
Published: (2022-08-01)

The Role of High Sensitivity C-Reactive Protein as a Predictor in Outcome ST - Elevation Acute Myocardial Infarction Patients Underwent the Primary Percutaneous Coronary Intervention
by: IGde Rurus SURYAWAN, et al.
Published: (2023-09-01)

Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial
by: Sajad Khiali, et al.
Published: (2023-10-01)

Managed Care after Acute Myocardial Infarction (KOS-zawał) reduces major adverse cardiovascular events by 45% in 3-month follow-up – single-center results of Poland’s National Health Fund program of comprehensive post-myocardial infarction care
by: Krystian Wita, et al.
Published: (2019-06-01)

The association between plasma furin and cardiovascular events after acute myocardial infarction
by: Zhi-Wei Liu, et al.
Published: (2021-09-01)

Modifying effect of diabetes on the short-term effect of clopidogrel in patients with myocardial infarction
by: Wuxiang Xie, et al.
Published: (2018-01-01)

Prognostic Role of Basophils to Predict Major Adverse Cardiac Cerebrovascular Events in ST Elevation Myocardial Infarction Patients: Egyptian PCI-Capable Center Experience
by: Walid Mohamed Kamel Ahmed, et al.
Published: (2021-12-01)

Symmetric Dimethylarginine is Altered in Patients After Myocardial Infarction and Predicts Adverse Outcomes
by: Gąsecka A, et al.
Published: (2021-08-01)

Growth Differentiation Factor-15 (GDF-15) as a Predictor of Major Adverse Cardiac Event in Acute Myocardial Infarction Patients
by: Annisa Tridamayanti, et al.
Published: (2022-04-01)

Microtubule destabilization with colchicine increases the work output of myocardial slices
by: Emmaleigh N. Hancock, et al.
Published: (2024-03-01)

Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis of Randomized Trials
by: Thomas Kofler, et al.
Published: (2021-08-01)

C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study
by: Wolfgang Ries, et al.
Published: (2021-03-01)

Comparison of In-hospital Major Adverse Cardiovascular Events in Patients of Acute Inferior Myocardial Infarction With or Without Precordial ST Segment Depression
by: Jaya Suganti, et al.
Published: (2017-04-01)

Influence of prediabetes on the prognosis of patients with myocardial infarction: a meta-analysis
by: Mengya Zeng, et al.
Published: (2024-07-01)

The impact of inflammation on Resistin, IL-6 and CRP in Acute Myocardial Infarction Patients.
by: Ammal E. Ibrahim, et al.
Published: (2011-07-01)

Predictive Value of Estimated Glomerular Filtration Rate for the Prognosis of Elderly Patients With Acute Myocardial Infarction
by: Namkyun Kim, et al.
Published: (2017-03-01)

Plasma concentration of TMAO is an independent predictor of adverse outcomes in patients after acute myocardial infarction
by: Aleksandra Gąsecka, et al.
Published: (2023-01-01)

EFFECTS OF N-ACETYLCYSTEIN ON HSCRP LEVEL IN ACUTE MYOCARDIAL INFARCTION PATIENTS RECEIVING FIBRINOLYTIC THERAPY
by: Savithri Indriani, et al.
Published: (2019-09-01)

Galectin-3 as a Prognostic Biomarker in Patients with First Acute Myocardial Infarction without Heart Failure
by: Rada M. Vucic, et al.
Published: (2023-10-01)

A Prediction Model Based on Systemic Immune-Inflammatory Index Combined with Other Predictors for Major Adverse Cardiovascular Events in Acute Myocardial Infarction Patients
by: Li X, et al.
Published: (2024-02-01)

Using the Super Learner algorithm to predict risk of major adverse cardiovascular events after percutaneous coronary intervention in patients with myocardial infarction
by: Xiang Zhu, et al.
Published: (2024-03-01)

Correlation analysis between the expression of serum microRNA-665 and the degree of coronary artery stenosis and major adverse cardiovascular events in patients with acute myocardial infarction
by: Chen Wang, et al.
Published: (2024-09-01)

Impact of Three-Dimensional Strain on Major Adverse Cardiovascular Events after Acute Myocardial Infarction Managed by Primary Percutaneous Coronary Intervention—A Pilot Study
by: Raluca Tomoaia, et al.
Published: (2021-09-01)

SYNTAX score as predictor of adverse events in patients after acute myocardial infarction
by: Davidović Aleksandar, et al.
Published: (2021-01-01)

NLRP3 inflammasome in the pathogenesis of acute myocardial infarction: a cardiologist's view
by: V. V. Ryabov, et al.
Published: (2024-05-01)

Clinical characteristics and outcomes of young adults with first myocardial infarction: Results from Gulf COAST
by: Abdulhamied Alfaddagh, et al.
Published: (2020-12-01)

Nocturnal Hypoxemia Due to Obstructive Sleep Apnea Is an Independent Predictor of Poor Prognosis After Myocardial Infarction
by: Jiang Xie, et al.
Published: (2016-08-01)

Serum irisin correlates to the severity of acute myocardial infarction and predicts the postoperative major adverse cardiovascular events
by: Qiaoying Chai, et al.
Published: (2023-09-01)

What is the lowest lethal dose of colchicine?
by: Vanyo Mitev
Published: (2023-03-01)

Longitudinal change of serum exosomal miR-186-5p estimates major adverse cardiac events in acute myocardial infarction patients receiving percutaneous coronary intervention
by: Lingyun Ren, et al.
Published: (2024-04-01)